Rare diseases
Investigational molecules
Locations
Back to Hungary22 clinical trials in Salgotarjan, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
HungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryHungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including studies of novel therapeutic combinations and targeted therapies.
Research includes evaluation of new drug combinations and sequential therapy approaches for improved patient outcomes.
Groundbreaking research on non-small cell lung cancer treatments, particularly focusing on advanced and metastatic cases with specific biomarker profiles.
Studies emphasize personalized treatment approaches based on molecular markers.
Clinical trials investigating new treatments for head and neck squamous cell carcinoma, including both HPV-negative and recurrent/metastatic cases.
Research focuses on improving survival rates through innovative therapeutic combinations.
Studies addressing metastatic castration-resistant prostate cancer, evaluating new treatment options and therapeutic combinations.
Trials aim to improve outcomes for patients with advanced disease stages.
Studies examining treatments for cardiovascular diseases and related conditions, including stroke prevention and obesity management.
Research focuses on both therapeutic interventions and preventive approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
